1. FRI0056 Serum IL-10 and IP-10 Levels is an Important Predictor of Response to Tocilizumab in Bio-Naïve RA Patients. (9th June 2015) Authors: Kameda, T.; Dobashi, H.; Inoo, M.; Onishi, I.; Kurata, N.; Susaki, K.; Wakiya, R.; Ozaki, H.; Nakashima, S.; Shimada, H.; Takeuchi, Y.; Izumikawa, M. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 439 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗